Tag Archives: Advanced PCa

Provenge available for men with advanced prostate cancer at Roswell Park

February 7 2011, BUFFALO, NY — The nation’s first FDA-approved cancer treatment vaccine, Provenge (sipuleucel-T), is being offered for the first time in Western New York at Roswell Park Cancer Institute (RPCI). The vaccine is designed for men with advanced prostate cancer who have limited treatment options and who meet eligibility requirements. Continue reading Provenge available for men with advanced prostate cancer at Roswell Park